| Literature DB >> 32153115 |
Ying Dong1, Linlin Jiang2, Xin Wang2, Zuo Chen2, Linfeng Zhang2, Zugui Zhang3, Congyi Zheng2, Yuting Kang2, Zengwu Wang2, Huiqing Cao, Xiaoxia Wang, Tian Fang, Xiaoyan Han, Zhe Li, Ye Tian, Lihang Dong, Fengyu Sun, Fucai Yuan, Xin Zhou, Yunyang Zhu, Yi He, Qingping Xi, Ruihai Yang, Jun Yang, Yong Ren, Maiqi Dan, Yiyue Wang, Daming Yu, Ru Ju, Dongshuang Guo, Dahua Tan, Zhiguo Zheng, Jingjing Zheng, Yang Xu, Dongsheng Wang, Tao Chen, Meihui Su, Yongde Zhang, Zhanhang Sun, Chen Dai.
Abstract
The purpose of this study was to assess the association of blood pressure (BP) measurements with the risk of cardiovascular disease (CVD) and examine whether central systolic BP (CSBP) predicts CVD better than brachial BP measurements (SBP and pulse pressure [PP]). Based on a cross-sectional study conducted in 2009-2010 with follow-up in 2016-2017 among 35- to 64-year-old subjects in China, we evaluated the performance of non-invasively predicted CSBP over brachial BP measurements on the first CVD events. Each BP measurement, individually and jointly with another BP measurement, was entered into the multivariate Cox proportional-hazards models, to examine the predictability of central and brachial BP measurements. Mean age of participants (n = 8710) was 50.1 years at baseline. After a median follow-up of 6.36 years, 187 CVD events occurred. CSBP was a stronger predictor for CVD than brachial BP measurements (CSBP, 1-standard deviation increment HR = 1.49, 95%CI: 1.31-1.70). With CSBP and SBP entering into models jointly, the HR for CSBP and SBP was 1.28 (1.04-1.58) and 1.22 (0.98-1.50), respectively. With CSBP and PP entering into models jointly, the HR for CSBP and PP was 1.51 (1.28-1.78) and 0.98 (0.83-1.15), respectively. For subgroup analysis, the association of CSBP with CVD was stronger than brachial BP measurements in women, those with hypertension and obesity. In the middle-aged Chinese population, noninvasively estimated CSBP may offer advantages over brachial BP measurements to predict CVD events, especially for participants with higher risk. These findings suggest prospective assessment of CSBP as a prevention and treatment target in further trials.Entities:
Keywords: Chinese; cardiovascular disease; central systolic blood pressure; cohort study
Mesh:
Year: 2020 PMID: 32153115 PMCID: PMC8029759 DOI: 10.1111/jch.13838
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738